Olympus Corporation - ADR logo

Olympus Corporation - ADR (OLYMY)

Market Open
5 Dec, 21:00
OTC PINK OTC PINK
$
13. 09
+0.03
+0.23%
$
2.84T Market Cap
51.17 P/E Ratio
72% Div Yield
174,900 Volume
0 Eps
$ 13.06
Previous Close
Day Range
13.06 13.58
Year Range
11.09 16.29
Want to track OLYMY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

OLYMY trading today higher at $13.09, an increase of 0.23% from yesterday's close, completing a monthly decrease of -1.13% or $0.15. Over the past 12 months, OLYMY stock lost -12.15%.
OLYMY is not paying dividends to its shareholders.
The last earnings report, released on Nov 10, 2025, exceeded the consensus estimates by 0.12%. On average, the company has surpassed earnings expectations by 0.11%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

OLYMY Chart

Similar

SK Hynix Inc.
$ 41.71
0%
Olympus Corporation
$ 13
+12.26%
Omron Corporation
$ 29.5
0%
Tencent Holdings Ltd UNS ADR
$ 77.74
-0.59%
Tencent Holdings Ltd.
$ 78.3
0%

Olympus Corporation - ADR (OLYMY) FAQ

What is the stock price today?

The current price is $13.09.

On which exchange is it traded?

Olympus Corporation - ADR is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is OLYMY.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 72%.

What is its market cap?

As of today, the market cap is 2.84T.

Has Olympus Corporation - ADR ever had a stock split?

No, there has never been a stock split.

Olympus Corporation - ADR Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Mr. Stefan Kaufmann CEO
OTC PINK Exchange
JP3201200007 ISIN
Japan Country
28,838 Employees
- Last Dividend
9 Apr 2019 Last Split
- IPO Date

Overview

Olympus Corporation, originally known as Olympus Optical Co., Ltd., is a global leader in the manufacturing and sale of precision machinery and instruments. The company has a rich history that dates back to its inception in 1919 and has its headquarters situated in Tokyo, Japan. Over the years, Olympus Corporation has undergone significant transformations, including a name change in October 2003, to better reflect its diversified product range and global presence. Olympus operates through four main business segments: Endoscopic Solutions, Therapeutic Solutions, Scientific Solutions, and Others. Each of these segments is geared towards providing innovative solutions in their respective fields, contributing to Olympus's reputation as a pioneer in medical and scientific equipment.

Products and Services

  • Endoscopic Solutions Business

    This segment delivers a comprehensive array of gastrointestinal and surgical endoscopy systems alongside surgical microscopes. Olympus also offers endoscope reprocessors and maintenance services, ensuring the durability and reliability of its endoscopic products. The focus here is on enhancing the efficiency of medical procedures and improving patient outcomes through state-of-the-art imaging and minimally invasive techniques.

  • Therapeutic Solutions Business

    Olympus's offering in this domain includes a variety of products for urology, gynecology, respiratory care, as well as ear, nose, and throat (ENT) treatments. The segment is particularly noted for its GI endo-therapy devices, energy devices, and surgical single-use devices, which are designed to facilitate complex therapeutic procedures with precision and care.

  • Scientific Solutions Business

    This segment caters to the needs of the scientific community, providing biological and industrial microscopes, industrial videoscopes, and non-destructive testing equipment. Additionally, Olympus supplies X-ray fluorescence (XRF) analyzers, instruments key in material analysis across various industries. The focus here is on delivering precision, enhancing research capabilities, and contributing to the advancement of science and industry.

  • Others

    Under this segment, Olympus develops and supplies biomedical materials such as synthetic bone fillers and orthopedic equipment. These products are a testament to Olympus’s commitment to extending its technological expertise beyond traditional boundaries and meeting the diverse needs of its global clientele.

Contact Information

Address: Shinjuku Monolith
Phone: 81 3 3340 2111